India’s smallcap universe has more than doubled in value since April 2023, leaving investors to confront a difficult question: after such a powerful rally, is it time to shift to largecaps? Vikas Khemani, founder of Carnelian Capital, believes the answer is no.

“Small caps are the India story,” Khemani wrote in Carnelian’s latest investor letter. 4 times increase for largecaps.

5 times trailing earnings, against 21 times for largecaps. But Carnelian argues that the headline valuation gap does not capture the difference in earnings growth or business composition.

On FY27 estimates, the valuation gap narrows to 27 times earnings for smallcaps versus 20 times for large caps. On a like-for-like comparison of domestic, non-financial companies, smallcaps trade at about 30 times FY27 earnings, compared with 33 times for large caps.

“Compare like with like, and small caps are cheaper,” Carnelian said.. Which signal should investors trust?

Smallcaps offer a purer domestic India exposureThe central argument is that smallcaps are more closely linked to the domestic economy than the largecap index. Around 59% of smallcap profits come from India’s domestic, non-financial economy, including factories, hospitals, retailers and builders.

For largecaps, the comparable share is 32%, with a much greater contribution from banks, global commodities and information technology. Carnelian’s analysis of 1,594 listed Indian companies found that small and midcaps have a larger representation in healthcare, industrials, consumer discretionary and materials.

By market value, healthcare accounts for 12% of small and midcaps compared with 5% for largecaps. In contrast, financials, energy, IT and utilities account for 51% of largecaps, compared with 30% of small and midcaps.

That distinction has become more important because domestic and global businesses have been moving in different directions. 4% annually.

Khemani also sees the strongest representation of emerging Indian themes in the smallcap universe. None of the nine listed electronics manufacturers and none of the 13 railway companies in Carnelian’s universe are large caps.

Of 15 hospital and diagnostics companies, only one is a large cap. Small companies in these newer themes grew profits at a median annual rate of 33% between FY20 and FY26.